ArticleJournal of studies on alcohol and drugs2011
A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
Article in Journal of studies on alcohol and drugs, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 29 citations in OpenAlex.
- The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.Journal of studies on alcohol and drugs · 2014Trial
- Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.Journal of substance abuse treatment · 2020Article
- Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020Review
- Receipt of Pharmacotherapy for Alcohol Use Disorder by Male Justice-Involved U.S. Veterans Health Administration Patients.Criminal justice policy review · 2018Article
- State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder.Psychiatric services (Washington, D.C.) · 2018Article
- Use of evidence-based treatments in substance abuse treatment programs serving American Indian and Alaska Native communities.Drug and alcohol dependence · 2016Article
- Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: Data from a national sample of treatment organizations.Substance abuse · 2016Article
- Sustained, new, never, and discontinued tobacco cessation services adopters.Journal of substance abuse treatment · 2015Article
- Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.Substance abuse · 2015Article
- Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse.Journal of substance abuse treatment · 2015Article
- Adoption of injectable naltrexone in U.S. substance use disorder treatment programs.Journal of studies on alcohol and drugs · 2015Article
- Rural substance use treatment centers in the United States: an assessment of treatment quality by location.The American journal of drug and alcohol abuse · 2015Article
- Examining the sustainment of the Adolescent-Community Reinforcement Approach in community addiction treatment settings: protocol for a longitudinal mixed method study.Implementation science : IS · 2014Article
- A quasi-experimental study examining New York State's tobacco-free regulation: effects on clinical practice behaviors.Drug and alcohol dependence · 2013Article
- Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.Journal of studies on alcohol and drugs · 2013Article
- Mentoring support from clinical supervisors: mentor motives and associations with counselor work-to-nonwork conflict.Journal of substance abuse treatment · 2013Article
- The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research.Implementation science : IS · 2012Review
- Clinical supervisor and counselor perceptions of clinical supervision in addiction treatment.Journal of addictive diseases · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
objectiveThe objectives of this study were to (a) identify the patterns of disulfiram (Antabuse) and tablet naltrexone (Revia) adoption over a 48-month period in a nationally representative sample of privately funded programs that deliver substance use disorder treatment; (b) examine predictors of sustainability, later adoption, discontinuation, and nonadoption of disulfiram and tablet naltrexone; and (c) measure reasons for medication discontinuation.
methodTwo waves of data were collected via face-to-face structured interviews with 223 program administrators.
resultsThese data demonstrated that adoption of medications for alcohol use disorders (AUDs) was a dynamic process. Although nonadoption was the most common pattern, approximately 20% of programs sustained use of the AUD medications and 30% experienced organizational change in adoption over the study period. Bivariate multinomial logistic regression models revealed that organizational characteristics were associated with sustainability including location in a hospital setting, program size, accreditation, revenues from private insurance, referrals from the criminal justice system, number of medical staff, and use of selective serotonin reuptake inhibitors at baseline. Two patterns of discontinuation were found: Programs either discontinued use of all substance use disorder medications or replaced disulfiram/tablet naltrexone with a newer AUD medication.
conclusionsThese findings suggest that adoption of AUD medications may be positively affected by pressure from accreditation bodies, partnering with primary care physicians, medication-specific training for medical staff, greater availability of resources to cover the costs associated with prescribing AUD medications, and amending criminal justice contracts to include support for AUD medication use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.